Time between treatment and PSA recurrence predicts death from prostate cancer

(Fox Chase Cancer Center) Men whose prostate specific antigen rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented today at the annual meeting of the American Society for Radiation Oncology.

source : www.eurekalert.org

Related News:

• SGO: New Option for Recurrent Ovarian Cancer? (CME/CE)
• Impact Of Ethnicity On Primary Treatment Choice And Mortality In Men With Prostate Cancer: Data From CaPSURE
• Gaps Remain in Cancer Palliative Care (CME/CE)
• Cordyceps mushroom is an effective cancer treatment, states new research
• Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
• Genetic variations influence statin efficacy for lowering colon cancer risk
• Heart transplant patients face greater risk of skin cancer
• How Cells Protect Themselves From Cancer
• The optimal Rx for pancreatic cancer: Stop it before it starts
• Final-phase trial underway for everolimus in gastric cancer